MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

Zoetis Inc

Open

BrancheGesundheitswesen

151.19 -0.21

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

150.15

Max

152.48

Schlüsselkennzahlen

By Trading Economics

Einkommen

-101M

581M

Verkäufe

-83M

2.3B

KGV

Branchendurchschnitt

26.846

57.333

EPS

1.4

Dividendenrendite

1.35

Gewinnspanne

25.076

Angestellte

13,800

EBITDA

-133M

906M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+34.52% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.35%

2.63%

Nächstes Ergebnis

6. Mai 2025

Nächstes Ex-Dividendendatum

16. Juli 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-13B

66B

Vorheriger Eröffnungskurs

151.4

Vorheriger Schlusskurs

151.19

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

Zoetis Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

4. Nov. 2024, 12:47 UTC

Ergebnisse

Zoetis Lifts Guidance On Strong Demand as 3Q Beats Market Views

6. Aug. 2024, 11:52 UTC

Ergebnisse

Zoetis Raises Guidance After 2Q Sales, Earnings Rise

20. Feb. 2025, 08:00 UTC

Top News

A Bird-Flu Vaccine Could Bring Down Egg Prices. Why the Poultry Industry Is Fighting It. -- Barrons.com

13. Feb. 2025, 13:47 UTC

Ergebnisse

Zoetis Plunges 9% As 2025 Guidance Misses Expectations -- IBD

13. Feb. 2025, 12:09 UTC

Ergebnisse

Zoetis Sees FY25 Adj EPS $6-Adj EPS $6.10 >ZTS

13. Feb. 2025, 12:08 UTC

Ergebnisse

Zoetis Sees FY25 Rev $9.225B-$9.375B >ZTS

13. Feb. 2025, 12:08 UTC

Ergebnisse

Zoetis Sees FY25 EPS $5.70-EPS $5.80 >ZTS

13. Feb. 2025, 12:00 UTC

Ergebnisse

Zoetis 4Q EPS $1.29 >ZTS

13. Feb. 2025, 12:00 UTC

Ergebnisse

Zoetis 4Q Rev $2.32B >ZTS

13. Feb. 2025, 12:00 UTC

Ergebnisse

Zoetis 4Q Net $581M >ZTS

4. Nov. 2024, 14:05 UTC

Ergebnisse

Zoetis Barks Up A Third-Quarter Beat And Raise, But Stock Slips -- IBD

4. Nov. 2024, 12:06 UTC

Ergebnisse

Zoetis Sees 2024 Rev $9.2B-$9.3B >ZTS

4. Nov. 2024, 12:06 UTC

Ergebnisse

Zoetis Sees 2024 Adj EPS $5.86-Adj EPS $5.92 >ZTS

4. Nov. 2024, 12:05 UTC

Ergebnisse

Zoetis 3Q Adj EPS $1.58 >ZTS

4. Nov. 2024, 12:00 UTC

Ergebnisse

Zoetis 3Q Net $682M >ZTS

4. Nov. 2024, 12:00 UTC

Ergebnisse

Zoetis 3Q EPS $1.50 >ZTS

4. Nov. 2024, 12:00 UTC

Ergebnisse

Zoetis 3Q Rev $2.39B >ZTS

6. Aug. 2024, 11:44 UTC

Ergebnisse

Zoetis Earnings Growth Picks Up, Tops Views -- IBD

6. Aug. 2024, 11:09 UTC

Ergebnisse

Zoetis Raises 2024 Operational Revenue Growth View to 9%-11% >ZTS

6. Aug. 2024, 11:08 UTC

Ergebnisse

Zoetis Raises 2024 View To Adj EPS $5.78-Adj EPS $5.88 >ZTS

6. Aug. 2024, 11:08 UTC

Ergebnisse

Zoetis Raises 2024 View To Rev $9.1B-$9.25B >ZTS

6. Aug. 2024, 11:08 UTC

Ergebnisse

Zoetis 2Q Adj EPS $1.56 >ZTS

6. Aug. 2024, 11:00 UTC

Ergebnisse

Zoetis 2Q Net $624M >ZTS

6. Aug. 2024, 11:00 UTC

Ergebnisse

Zoetis 2Q Rev $2.36B >ZTS

6. Aug. 2024, 11:00 UTC

Ergebnisse

Zoetis 2Q EPS $1.37 >ZTS

2. Mai 2024, 17:43 UTC

Ergebnisse

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2. Mai 2024, 13:06 UTC

Ergebnisse

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2. Mai 2024, 11:27 UTC

Ergebnisse

Zoetis Earnings Top; Pet Drugmaker Rises -- IBD

2. Mai 2024, 11:00 UTC

Ergebnisse

Zoetis 1Q Net $599M >ZTS

2. Mai 2024, 11:00 UTC

Ergebnisse

Zoetis 1Q EPS $1.31 >ZTS

Peer-Vergleich

Kursveränderung

Zoetis Inc Prognose

Kursziel

By TipRanks

34.52% Vorteil

12-Monats-Prognose

Durchschnitt 204.88 USD  34.52%

Hoch 242 USD

Tief 165 USD

Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Zoetis Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

8 ratings

7

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

147 / 152.64Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Weak Bullish Evidence

Langfristig

Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.